K203855 is an FDA 510(k) clearance for the CoNextions TR Tendon Repair System. Classified as Suture, Nonabsorbable, Steel, Monofilament And Multifilament, Sterile (product code GAQ), Class II - Special Controls.
Submitted by Conextions Medical (Salt Lake City, US). The FDA issued a Cleared decision on April 22, 2022 after a review of 477 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4495 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.
View all Conextions Medical devices
NCT03622372
Active not recruiting
Interventional
Industry-sponsored
Zone 2 Flexor Tendon Repair With CoNextions TR Implant System
Pivotal, Randomised, Controlled Trial to Evaluate the Safety and Effectiveness of the CoNextions TR Implant System for Zone 2 Flexor Tendon Repair
| Condition studied |
Tendon Injury - Hand |
| Study design |
Parallel |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
Michael Solomons, MD |
| Sponsor |
CoNextions Medical
(industry)
|
Started 2018-06-21
→
Primary completion 2020-06-20
→
Completed 2020-12-01
Primary outcome
Rate of tendon re-rupture
Secondary outcome
Visual Analog Score (VAS) for Pain Assessment (0-10 cm scale)
View full study on ClinicalTrials.gov